These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15243219)

  • 21. Managing dyslipidemia in the high-risk patient.
    Stein EA
    Am J Cardiol; 2002 Mar; 89(5A):50C-57C. PubMed ID: 11900720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin therapy and the elderly: SAGE advice?
    Gotto AM
    Circulation; 2007 Feb; 115(6):681-3. PubMed ID: 17296867
    [No Abstract]   [Full Text] [Related]  

  • 23. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early initiation of statin therapy after a coronary event.
    McKeown B; Thompson PL
    Curr Opin Lipidol; 2002 Dec; 13(6):631-5. PubMed ID: 12441887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study.
    Kashima Y; Izawa A; Aizawa K; Koshikawa M; Kasai H; Tomita T; Kumazaki S; Tsutsui H; Koyama J; Ikeda U
    J Cardiol; 2009 Aug; 54(1):76-9. PubMed ID: 19632524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins and coronary heart disease.
    Fey R; Pearson N
    Lancet; 1996 May; 347(9012):1389-90. PubMed ID: 8637349
    [No Abstract]   [Full Text] [Related]  

  • 27. [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
    Karie S; Launay-Vacher V; Deray G; Isnard-Bagnis C
    Presse Med; 2006 Feb; 35(2 Pt 1):219-29. PubMed ID: 16493350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cost-effectiveness of statins. Review].
    Moriguchi H; Goto Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():513-7. PubMed ID: 11347123
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.
    Albert MA; Danielson E; Rifai N; Ridker PM;
    JAMA; 2001 Jul; 286(1):64-70. PubMed ID: 11434828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins for prevention of stroke.
    Rosendorff C
    Lancet; 1998 Apr; 351(9108):1002-3. PubMed ID: 9546501
    [No Abstract]   [Full Text] [Related]  

  • 31. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.
    Hunt D; Young P; Simes J; Hague W; Mann S; Owensby D; Lane G; Tonkin A
    Ann Intern Med; 2001 May; 134(10):931-40. PubMed ID: 11352694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroke prevention, blood cholesterol, and statins.
    Amarenco P; Lavallée P; Touboul PJ
    Lancet Neurol; 2004 May; 3(5):271-8. PubMed ID: 15099541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
    Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
    Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis.
    Afilalo J; Duque G; Steele R; Jukema JW; de Craen AJ; Eisenberg MJ
    J Am Coll Cardiol; 2008 Jan; 51(1):37-45. PubMed ID: 18174034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Where to draw the line using statins: lessons from 4S to AFCAPS/TexCAPS.
    Sprecher DL
    Cleve Clin J Med; 2000 Mar; 67(3):169-71. PubMed ID: 10743305
    [No Abstract]   [Full Text] [Related]  

  • 36. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit.
    Wright RS; Murphy JG; Bybee KA; Kopecky SL; LaBlanche JM
    Mayo Clin Proc; 2002 Oct; 77(10):1085-92. PubMed ID: 12374252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pravastatin benefits elderly patients: results of PROSPER study.
    Cardiovasc J S Afr; 2003; 14(1):48. PubMed ID: 12728925
    [No Abstract]   [Full Text] [Related]  

  • 39. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.